Margaret E. McCann - Concepedia

Concepedia

Author

Margaret E. McCann

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

M. E. McCann, M. McCANN, Margaret E. McCann

21

Publications

1.5K

Citations

16

H-Index

37

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of Georgia

ME

About

Margaret E. McCann is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	410
2	Biochemistry	4	4	238
3	Health Sciences	2	2	52
4	Natural Sciences	2	2	169
5	Public Health	1	1	31

Margaret E. McCann

×

17

Publications

1.5K

Citations

16

H-Index

	Year	Citations
(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes Dooseop Kim, Liping Wang, Maria Beconi, Journal of Medicinal Chemistry	2004	808
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis Margaret E. McCann, Donald R. Andersen, Donghui Zhang, American Journal of Veterinary Research	2004	114
Extracellular loop C of NPC1L1 is important for binding to ezetimibe Adam B. Weinglass, Martin Köhler, Uwe Schulte, Proceedings of the National Academy of Sciences Proteinlipid InteractionMolecular BiologyCytoskeletonCellular PhysiologyDog Npc1l1	2008	113
Selective PPARγ modulators with improved pharmacological profiles Kun Liu, Regina M. Black, John J. Acton, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyG Protein-coupled ReceptorMedicineFunctional SelectivityPharmacological Agent	2005	62
Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Weiguo Liu, Fiona WaiYu Lau, Kun Liu, Journal of Medicinal Chemistry PharmacotherapyExperimental PharmacologyGene Expression ProfilingPharmaceutical ChemistryTranslational Pharmacology	2011	56
Discovery of (2<i>R</i>)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume John J. Acton, Taro E. Akiyama, Ching H. Chang, Journal of Medicinal Chemistry	2009	52
Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core Dong‐Ming Shen, Edward J. Brady, Mari R. Candelore, Bioorganic & Medicinal Chemistry Letters BiochemistryG Protein-coupled ReceptorMedicineFunctional SelectivityMechanism Of Action	2010	47
Effects of acetylpromazine, xylazine, and vertical load on digital arterial blood flow in horses Robert J. Hunt, Christopher Brandon, Margaret E. McCann American Journal of Veterinary Research	1994	43
EFFECT OF INTRAVENOUS INFUSION OF OMEGA-3 AND OMEGA-6 LIPID EMULSIONS ON EQUINE MONOCYTE FATTY ACID COMPOSITION AND INFLAMMATORY MEDIATOR PRODUCTION IN VITRO Margaret E. McCann, James N. Moore, Joan Carrick, Shock	2000	39
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia Margaret E. McCann, Eric L. Rickes, Donald F. Hora, American Journal of Veterinary Research	2005	39

Page 1